triple agonist retatrutide First phase 3 data, a Triumph of Science! triple hormone receptor agonist retatrutide
Description
Educational only
Typically, semaglutide doses are increased every four weeks if the medication is well tolerated
GLP-1 medications, by contrast, may face supply shortages, require specialty pharmacy fulfillment, and involve navigating prior authorization processes that can delay treatment by weeks
Splitting a dose across two syringes introduces extra steps and more opportunities for error
